Laura A Goff, MD

Official Affiliation: Medicine

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer. Cardin DB, Goff L, Li CI, Shyr Y, Winkler C, DeVore R, Schlabach L, Holloway M, McClanahan P, Meyer K, Grigorieva J, Berlin J, Chan E (2014) Cancer Med 3(3): 572-9
    › Primary publication · 24574334 (PubMed) · PMC4101748 (PubMed Central)
  2. Advanced biliary tract cancers. Goff LW, Berlin JD (2012) Am Soc Clin Oncol Educ Book : 281-2
    › Primary publication · 24451749 (PubMed)
  3. Targeting the HGF-cMET Axis in Hepatocellular Carcinoma. Venepalli NK, Goff L (2013) Int J Hepatol : 341636
    › Primary publication · 23606971 (PubMed) · PMC3626399 (PubMed Central)
  4. Safety, pharmacokinetics and pharmacodynamics of the anti-A33 fully-human monoclonal antibody, KRN330, in patients with advanced colorectal cancer. Infante JR, Bendell JC, Goff LW, Jones SF, Chan E, Sudo T, Burris HA, Berlin JD (2013) Eur J Cancer 49(6): 1169-75
    › Primary publication · 23294608 (PubMed)
  5. Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review. Chi M, Mikhitarian K, Shi C, Goff LW (2012) Gastrointest Cancer Res 5(6): 199-202
    › Primary publication · 23293701 (PubMed) · PMC3533848 (PubMed Central)
  6. Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers. Bekaii-Saab T, Phelps MA, Li X, Saji M, Goff L, Kauh JS, O'Neil BH, Balsom S, Balint C, Liersemann R, Vasko VV, Bloomston M, Marsh W, Doyle LA, Ellison G, Grever M, Ringel MD, Villalona-Calero MA (2011) J Clin Oncol 29(17): 2357-63
    › Primary publication · 21519026 (PubMed) · PMC3107751 (PubMed Central)
  7. Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinoma. O'Neil BH, Goff LW, Kauh JS, Strosberg JR, Bekaii-Saab TS, Lee RM, Kazi A, Moore DT, Learoyd M, Lush RM, Sebti SM, Sullivan DM (2011) J Clin Oncol 29(17): 2350-6
    › Primary publication · 21519015 (PubMed) · PMC3107750 (PubMed Central)
  8. The insulin-like growth factor signaling pathway as a target for treatment of colorectal carcinoma. Ewing GP, Goff LW (2010) Clin Colorectal Cancer 9(4): 219-23
    › Primary publication · 20920993 (PubMed)
  9. Phase I study of oral irinotecan as a single-agent and given sequentially with capecitabine. Goff LW, Benson AB, LoRusso PM, Tan AR, Berlin JD, Denis LJ, Benner RJ, Yin D, Rothenberg ML (2012) Invest New Drugs 30(1): 290-8
    › Primary publication · 20857171 (PubMed)
  10. Esophageal adenocarcinoma: treatment modalities in the era of targeted therapy. Mukherjee K, Chakravarthy AB, Goff LW, El-Rifai W (2010) Dig Dis Sci 55(12): 3304-14
    › Primary publication · 20300841 (PubMed) · PMC2890301 (PubMed Central)
  11. Aurora kinase inhibitors--rising stars in cancer therapeutics? Dar AA, Goff LW, Majid S, Berlin J, El-Rifai W (2010) Mol Cancer Ther 9(2): 268-78
    › Primary publication · 20124450 (PubMed) · PMC2820587 (PubMed Central)
  12. Chemotherapy and immunotherapy in metastatic colorectal cancer. Pohlmann PR, Mernaugh RL, Goff LW (2009) N Engl J Med 360(20): 2134; author reply 2135-6
    › Primary publication · 19439750 (PubMed)
  13. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. Benson AB, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, Covey A, Curley SA, D'Angelica MI, Davila R, Ensminger WD, Gibbs JF, Laheru D, Malafa MP, Marrero J, Meranze SG, Mulvihill SJ, Park JO, Posey JA, Sachdev J, Salem R, Sigurdson ER, Sofocleous C, Vauthey JN, Venook AP, Goff LW, Yen Y, Zhu AX (2009) J Natl Compr Canc Netw 7(4): 350-91
    › Primary publication · 19406039 (PubMed) · PMC4461147 (PubMed Central)
  14. A phase I trial of irinotecan alternating with epirubicin in patients with advanced malignancies. Goff LW, Rothenberg ML, Lockhart AC, Roth BJ, VerMeulen WL, Chan E, Berlin JD (2008) Am J Clin Oncol 31(5): 413-6
    › Primary publication · 18838875 (PubMed)
  15. Role of chemotherapy for palliation in the lung cancer patient. Stinnett S, Williams L, Johnson DH (2007) J Support Oncol 5(1): 19-24
    › Primary publication · 17265782 (PubMed)
View full member profile

Featured Affiliation

View all affiliations

Contact Information

2220 Pierce Ave
777 PRB
Nashville, TN 37232
USA
615-322-4967 (p)
Email

Keywords & MeSH Terms

MeSH terms are retrieved from PubMed records. Learn more.

Key: MeSH Term Keyword

Antineoplastic Combined Chemotherapy Protocols Aurora Kinase A Barrett Esophagus Biliary Tract Cetuximab Chemotherapy, Adjuvant Clinical Trials as Topic Colorectal Neoplasms Drug Monitoring Drug Resistance, Neoplasm Epirubicin Extracellular Signal-Regulated MAP Kinases Fluorouracil Gene Expression Regulation, Neoplastic Guideline Adherence Humans Immunohistochemistry Insulin-Like Growth Factor I Lung Neoplasms Molecular Targeted Therapy Mutation Neoplasm Recurrence, Local Neoplasms Organoplatinum Compounds Pancreatic Neoplasms Protein-Serine-Threonine Kinases Quinazolines Sorafenib Treatment Outcome Vomiting